Phillip Parente
Impact in
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer survivorship and care
Papers in
- Oncology 50
- Cancer Treatment and Pharmacology 11
- Cancer Immunotherapy and Biomarkers 11
- Cancer survivorship and care 10
- CAR-T cell therapy research 9
-
- Prostate Cancer Treatment and Research 34
- Co-authors
- Ian D. Davis (19 shared papers)Jonathan Cebon (10 shared papers)Madeleine King (6 shared papers)Michael Jefford (4 shared papers)Pēteris Dārziņš (4 shared papers)A. L. Pope (4 shared papers)Wee Kheng Soo (4 shared papers)Wendie Hopkins (6 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Annals of Oncology (7 papers)Supportive Care in Cancer (4 papers)European Urology Focus (2 papers)The Lancet Healthy Longevity (2 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Phillip Parente
81 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Geriatrics and Gerontology 178
- Oncology 698
- Immunology 438
- Pulmonary and Respiratory Medicine 420
- Cancer Research 152
Countries citing papers authored by Phillip Parente
This map shows the geographic impact of Phillip Parente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Parente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Parente more than expected).
Fields of papers citing papers by Phillip Parente
This network shows the impact of papers produced by Phillip Parente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Parente. The network helps show where Phillip Parente may publish in the future.
Co-authors
The 25 scholars most cited alongside Phillip Parente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 163 | |
| 2 | 2022 | 112 | |
| 3 | 2003 | 111 | |
| 4 | The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. | 2004 | 96 |
| 5 | 2020 | 96 | |
| 6 | 2016 | 92 | |
| 7 | 2004 | 76 | |
| 8 | 2006 | 57 | |
| 9 | 2015 | 51 | |
| 10 | 2019 | 38 | |
| 11 | 2014 | 36 | |
| 12 | Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination. | 2005 | 33 |
| 13 | 2015 | 32 | |
| 14 | 2013 | 32 | |
| 15 | 2021 | 31 | |
| 16 | 2013 | 27 | |
| 17 | 2016 | 27 | |
| 18 | 2016 | 25 | |
| 19 | 2018 | 24 | |
| 20 | 2018 | 24 |
About Phillip Parente
Phillip Parente is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Immunology and Cancer Research, having authored 82 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (34 papers), Immunotherapy and Immune Responses (12 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Cancer Treatment and Pharmacology (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), Multiple Myeloma Research and Treatments (10 papers), Cancer survivorship and care (10 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Geriatrics and Gerontology (178 citations), Oncology (698 citations), Immunology (438 citations), Pulmonary and Respiratory Medicine (420 citations) and Cancer Research (152 citations). Phillip Parente has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Ian D. Davis, Jonathan Cebon, Madeleine King, Michael Jefford, Pēteris Dārziņš, A. L. Pope, Wee Kheng Soo, Wendie Hopkins, Heather Jackson and Weisan Chen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Supportive Care in Cancer, European Urology Focus and The Lancet Healthy Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.